FDA Approved: PREDNISOLONE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved a supplemental Abbreviated New Drug Application for a generic prednisolone product from PAI Holdings/PAI Pharma, signaling regulatory clearance und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Atopic Dermatitis
• Chronic Obstructive Pulmonary Disease
• Crohn Disease
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Ulcerative Colitis

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

SUPPL AP for PREDNISOLONE (PREDNISOLONE)